{"engines":218,"catalog_engines":307,"pipeline_engines":218,"total_engines":307,"engines_breakdown":{"legacy_symptom_intake":218,"clinician_side":89,"clinician_channel":88,"clinician_meta":1,"computed_total":307,"matches_expected_total":true},"evidence_map":[{"engine_number":25,"instrument":"Loneliness / Social Isolation Engine (Engine 25)","guideline_source":"PHQ"},{"engine_number":27,"instrument":"PrevenCard — Preventive Medicine Evidence-Based Engine (Engine 27).","guideline_source":"WHO; USPSTF"},{"engine_number":29,"instrument":"Endocrinology depth.","guideline_source":"ADA Standards of Care 2025 — DKA/HHS criteria; ATA 2014 Guidelines on Hypothyroidism + 2016 Hyperthyroidism"},{"engine_number":30,"instrument":"Cardiology depth.","guideline_source":"AHA/ACC/HFSA 2022 Heart Failure; ACC/AHA 2023 Atrial Fibrillation"},{"engine_number":31,"instrument":"Nephrology depth.","guideline_source":"KDIGO 2024 CKD Evaluation + Management; KDIGO 2012 AKI Clinical Practice Guideline"},{"engine_number":32,"instrument":"Pediatric Depth.","guideline_source":"AAP Bhutani nomogram (Pediatrics 1999); AAP Clinical Report on Evaluation of Suspected Child Physical Abuse (2015)"},{"engine_number":33,"instrument":"Pulmonology depth.","guideline_source":"GINA 2024 Asthma · GOLD 2025 COPD · ACCP PE guidelines · AASM OSA"},{"engine_number":34,"instrument":"Mental Health depth.","guideline_source":"APA / DSM-5-TR; USPSTF Depression Screening 2023"},{"engine_number":35,"instrument":"Hepatology.","guideline_source":"AASLD 2023 cirrhosis / HE / SBP; ACG 2023 ALF"},{"engine_number":36,"instrument":"Hematology depth.","guideline_source":"ASCO/IDSA 2018 febrile neutropenia; ASH 2019 ITP"},{"engine_number":37,"instrument":"Rheumatology.","guideline_source":"ACR 2021 SLE; ACR 2023 axSpA"},{"engine_number":38,"instrument":"Women's Health depth.","guideline_source":"ACOG 2023 hypertension in pregnancy; ACOG 2017 PPH"},{"engine_number":39,"instrument":"Men's Health depth.","guideline_source":"AUA 2023 BPH; AUA 2024 testis cancer"},{"engine_number":40,"instrument":"Dermatology depth.","guideline_source":"AAD 2023; NEJM 2017 SJS/TEN review"},{"engine_number":41,"instrument":"Ophthalmology depth.","guideline_source":"AAO 2024; Wills Eye Manual"},{"engine_number":42,"instrument":"ENT (Otolaryngology) depth.","guideline_source":"AAO-HNS 2019 SSNHL; IDSA"},{"engine_number":43,"instrument":"Toxicology depth.","guideline_source":"Goldfrank's Toxicologic Emergencies 12e; ACMT"},{"engine_number":44,"instrument":"Geriatrics depth.","guideline_source":"AGS Beers 2023; CFS Rockwood 2020"},{"engine_number":45,"instrument":"Oncology emergencies.","guideline_source":"NCCN 2024 oncology emergencies; ASCO supportive care"},{"engine_number":46,"instrument":"Ophthalmology Outpatient (chronic / preventive).","guideline_source":"AAO Preferred Practice Pattern 2024; ADA 2025"},{"engine_number":47,"instrument":"ENT Outpatient (chronic / non-emergency).","guideline_source":"AAO-HNS 2024; ICAR-RS 2021"},{"engine_number":48,"instrument":"General Surgery (adult).","guideline_source":"WSES 2020 sepsis; Tokyo Guidelines 2018 acute cholangitis"},{"engine_number":49,"instrument":"Accessibility / Communication-mode Audit.","guideline_source":"ADA"},{"engine_number":50,"instrument":"Disability Resources & Caregiver Support Hub.","guideline_source":"Curated US & India disability-support resource directory; non-clinical caregiver hub (verified org/govt URLs)"},{"engine_number":51,"instrument":"Acute Infectious Disease Expansion.","guideline_source":"CDC COVID-19, Influenza, RSV clinical guidance 2024-2026; IDSA Cellulitis/SSTI Guidelines 2014"},{"engine_number":52,"instrument":"Communicable / Vaccine-Preventable / Emerging Infectious Diseases.","guideline_source":"CDC Pertussis Surveillance and Treatment 2025; CDC Measles Outbreak Guidelines 2025"},{"engine_number":53,"instrument":"Engine 53 Phase B — Anticholinergic Burden / Drug-Induced Cognitive Risk","guideline_source":"Beers"},{"engine_number":68,"instrument":"Off-Label / Novel-Treatment Attestation Engine.","guideline_source":"FDA"},{"engine_number":69,"instrument":"pediatric_dose_safety_engine.py — Engine 69 (Wachter Ch. 2 — Septra UCSF 2013 case)","guideline_source":"Wachter, R. \"The Digital Doctor\" Ch. 2 (2015); ISMP \"List of High-Alert Medications in Acute Care Settings\" (2024)"},{"engine_number":70,"instrument":"renal_dose_adjustment_engine.py — Engine 70 (Wachter Ch. 4)","guideline_source":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of CKD; Wachter, R. \"The Digital Doctor\" Ch. 4 (2015)"},{"engine_number":71,"instrument":"hepatic_dose_adjustment_engine.py — Engine 71 (Wachter Ch. 4)","guideline_source":"AASLD Practice Guidance on Cirrhosis 2024; Wachter, R. \"The Digital Doctor\" Ch. 4 (2015)"},{"engine_number":72,"instrument":"max_daily_dose_engine.py — Engine 72 (Wachter Ch. 2, general principle)","guideline_source":"FDA Orange Book / prescribing information for listed drugs; ISMP \"List of High-Alert Medications\" (2024)"},{"engine_number":73,"instrument":"sbar_handoff_engine.py — Engine 73 (Wachter Ch. 5-6, hospitalist signature gap)","guideline_source":"Joint Commission \"Improving Handoff Communications\" Sentinel Event Alert (2024 update); AHRQ TeamSTEPPS SBAR module"},{"engine_number":74,"instrument":"handoff_diff_engine.py — Engine 74 (Wachter Ch. 6)","guideline_source":"Wachter, R. \"The Digital Doctor\" Ch. 6 (2015); I-PASS Handoff Study (Starmer 2014, NEJM)"},{"engine_number":75,"instrument":"cross_shift_attestation_engine.py — Engine 75 (Wachter Ch. 6)","guideline_source":"Wachter, R. \"The Digital Doctor\" Ch. 6 (2015); Joint Commission NPSG.02.05.01 (Hand-Off Communication)"},{"engine_number":76,"instrument":"orphaned_result_engine.py — Engine 76 (Wachter Ch. 7)","guideline_source":"Wachter, R. \"The Digital Doctor\" Ch. 7 (2015); AHRQ \"Improving Patient Safety in Test-Result Communication\" (2024)"},{"engine_number":77,"instrument":"copy_forward_detector_engine.py — Engine 77 (Wachter Ch. 5)","guideline_source":"Wachter, R. \"The Digital Doctor\" Ch. 5 (2015); AHRQ Common Formats for Adverse Event Reporting — Documentation"},{"engine_number":78,"instrument":"voice_observation_engine.py — Engine 78 (Topol Deep Medicine Ch. 4-6)","guideline_source":"Topol, E. \"Deep Medicine\" Ch. 4-6 (2019); Topol NIH AURORA project — voice biomarkers"},{"engine_number":79,"instrument":"wearable_narrative_engine.py — Engine 79 (Topol Deep Medicine Ch. 7)","guideline_source":"Topol, E. \"Deep Medicine\" Ch. 7 (2019); AHA Scientific Statement: Wearable Health Technology (2024)"},{"engine_number":80,"instrument":"genomic_context_engine.py — Engine 80 (Topol Deep Medicine Ch. 9)","guideline_source":"Topol, E. \"Deep Medicine\" Ch. 9 (2019); ACMG/AMP Variant Classification Guidelines 2024"},{"engine_number":81,"instrument":"mental_health_speech_engine.py — Engine 81 (Topol mental-health essays, 2023-2024)","guideline_source":"Topol, E. essays on speech biomarkers in depression (Lancet Digital Health 2023-2024); USPSTF Recommendation Statement on Depression Screening (2023)"},{"engine_number":82,"instrument":"Oncology Red-Flag Engine","guideline_source":"NCCN Guidelines (specialty per stated dx); ICD-10-CM 2026"},{"engine_number":83,"instrument":"Differential Diagnosis Aggregator (worst-first, 3-tier)","guideline_source":"Internal worst-first differential aggregation; consumes upstream engine red-flag tiers (meta-engine)"},{"engine_number":84,"instrument":"Acute Stroke Window Engine","guideline_source":"AHA/ASA Acute Ischemic Stroke Guideline 2019, updated 2024; DAWN trial (NEJM 2018) — EVT 24h window with imaging mismatch"},{"engine_number":85,"instrument":"Sepsis-3 Engine (qSOFA + lactate + organ-dysfunction triggers)","guideline_source":"Sepsis-3 Definitions (JAMA 2016, Singer et al.); Surviving Sepsis Campaign Adult Guidelines 2021"},{"engine_number":86,"instrument":"Anaphylaxis Recognition Engine","guideline_source":"World Allergy Organization (WAO) Anaphylaxis Guideline 2020; JAMA Network Open 2024 — Biphasic anaphylaxis incidence 4–20%"},{"engine_number":87,"instrument":"Pulmonary Embolism Engine (Wells score + PERC rule)","guideline_source":"Wells et al., Thromb Haemost 2000; Kline et al., PERC Rule, JTH 2004"},{"engine_number":88,"instrument":"Hypoglycemia in Elderly on Sulfonylurea","guideline_source":"ADA Standards of Care 2026 — Older Adults; Beers Criteria 2023 — glyburide AVOID in older adults"},{"engine_number":89,"instrument":"Pediatric Non-Accidental Trauma (NAT) Engine","guideline_source":"AAP Clinical Report on Abusive Head Trauma (Pediatrics 2020); TEN-4 FACESp Bruising Clinical Decision Rule (Pierce et al., JAMA Peds 2021)"},{"engine_number":90,"instrument":"Oncology Phase 2 Engine","guideline_source":"NCCN AML v3.2025, NCCN Acute Lymphoblastic Leukemia v2.2025; NCCN MDS v3.2025"},{"engine_number":91,"instrument":"NEWS2 (National Early Warning Score 2)","guideline_source":"Royal College of Physicians. National Early Warning Score (NEWS) 2.; Standardising the assessment of acute-illness severity in the NHS. 2017."},{"engine_number":92,"instrument":"VTE Prophylaxis Risk (Caprini RAM, full 2005/2010 model)","guideline_source":"Caprini JA. Thrombosis risk assessment as a guide to quality patient; care. Dis Mon 2005;51:70-78."},{"engine_number":93,"instrument":"Delirium Screen (4AT / CAM-ICU)","guideline_source":"Inouye SK et al. Clarifying confusion: the Confusion Assessment; Method. Ann Intern Med 1990."},{"engine_number":94,"instrument":"Fall Risk (Morse Fall Scale)","guideline_source":"Morse JM, Morse RM, Tylko SJ. Development of a scale to identify the; fall-prone patient. Can J Aging 1989."},{"engine_number":95,"instrument":"Alcohol Withdrawal Severity (CIWA-Ar)","guideline_source":"Sullivan JT et al. Assessment of alcohol withdrawal: the revised; CIWA-Ar. Br J Addict 1989."},{"engine_number":96,"instrument":"Neutropenic Fever Risk (MASCC Index)","guideline_source":"Klastersky J et al. The MASCC risk-index score. JCO 2000.; Freifeld AG et al. IDSA Clinical Practice Guideline for febrile"},{"engine_number":97,"instrument":"Tumor Lysis Syndrome (Cairo-Bishop criteria)","guideline_source":"Cairo MS, Bishop M. Br J Haematol 2004 (Cairo-Bishop classification).; Coiffier B et al. JCO 2008 (TLS guidelines)."},{"engine_number":98,"instrument":"Heparin-Induced Thrombocytopenia (4Ts score)","guideline_source":"Lo GK et al. J Thromb Haemost 2006 (4Ts score).; Cuker A et al. ASH 2018 guideline on HIT management."},{"engine_number":99,"instrument":"Thrombotic Thrombocytopenic Purpura (PLASMIC score)","guideline_source":"Bendapudi PK et al. Lancet Haematol 2017 (PLASMIC score).; Zheng XL et al. ASH 2020 guideline on TTP."},{"engine_number":100,"instrument":"Sickle Cell Vaso-Occlusive Crisis / Acute Chest Syndrome","guideline_source":"NHLBI Evidence-Based Management of Sickle Cell Disease, 2014.; ASH 2020 Guidelines for SCD: cardiopulmonary & kidney disease;"},{"engine_number":101,"instrument":"WHO IMCI (Integrated Management of Childhood Illness)","guideline_source":"WHO; IMCI"},{"engine_number":102,"instrument":"Traditional / Alternative Medicine Cross-System Pharmacology","guideline_source":"WHO"},{"engine_number":103,"instrument":"Caregiver Burden (Zarit Burden Interview)","guideline_source":"Zarit"},{"engine_number":104,"instrument":"Nursing Assessment Bundle","guideline_source":"Morse; CAM"},{"engine_number":105,"instrument":"Physical Therapy Outcomes Bundle (Patient-Self-Input ONLY)","guideline_source":"NICE"},{"engine_number":106,"instrument":"Pain Management & Opioid Stewardship.","guideline_source":"CDC 2022 Guideline; FDA Boxed Warning (opioid+benzo, 2016)"},{"engine_number":107,"instrument":"Gastroenterology Depth.","guideline_source":"ACG / AGA 2023-2024 guidelines; Tokyo Guidelines TG18"},{"engine_number":108,"instrument":"Obesity & Metabolic Medicine (GLP-1 era).","guideline_source":"ADA Standards of Care 2024; Endocrine Society Obesity Guidelines 2015/2024"},{"engine_number":109,"instrument":"Sleep Medicine.","guideline_source":"AASM 2023 guidelines; ICSD-3-TR 2023"},{"engine_number":110,"instrument":"Palliative & End-of-Life Medicine.","guideline_source":"AAHPM / HPNA; NCCN Palliative Care 2024"},{"engine_number":111,"instrument":"Trauma, Pre-Hospital & Snakebite (Health-Equity 24/7 Alert).","guideline_source":"WHO Snakebite Roadmap 2019; ICMR Indian National Snakebite Protocol"},{"engine_number":112,"instrument":"STI Expansion (broader than existing HIV-focused engine).","guideline_source":"CDC STI Treatment Guidelines 2021; CDC 2024 doxy-PEP"},{"engine_number":113,"instrument":"Musculoskeletal Outpatient (MSK).","guideline_source":"Ottawa Ankle/Knee rules (Stiell 1992-1996); ACR appropriateness criteria"},{"engine_number":114,"instrument":"Urology Outpatient.","guideline_source":"AUA 2024 guidelines; EAU 2024"},{"engine_number":115,"instrument":"Maternal Warning Signs.","guideline_source":"ACOG 2023 / WHO 2024 / FIGO Postpartum Hemorrhage / India MoHFW"},{"engine_number":116,"instrument":"Neonatal Warning Signs (<28 days of life).","guideline_source":"WHO Newborn Care 2020 / AAP 2024 / India National Neonatal-"},{"engine_number":117,"instrument":"STOPP/START Prescribing Review (older adults)","guideline_source":"O'Mahony D et al. STOPP/START criteria v3. Age Ageing 2023."},{"engine_number":118,"instrument":"HAS-BLED Bleeding Risk (atrial fibrillation / anticoagulation)","guideline_source":"Pisters R et al. A novel user-friendly score (HAS-BLED). Chest 2010."},{"engine_number":119,"instrument":"Dengue Severity / Warning Signs (WHO 2009)","guideline_source":"WHO. Dengue: Guidelines for Diagnosis, Treatment, Prevention and; Control. 2009."},{"engine_number":120,"instrument":"Severe Malaria Criteria (WHO)","guideline_source":"WHO. Guidelines for the Treatment of Malaria, 3rd ed. 2015 /; WHO Guidelines for Malaria 2023."},{"engine_number":121,"instrument":"Dehydration Severity & ORS Plan (WHO / IMCI)","guideline_source":"WHO. The Treatment of Diarrhoea: a manual for physicians, 4th rev. 2005.; WHO/UNICEF IMCI chart booklet."},{"engine_number":122,"instrument":"TIMI Risk Score (UA/NSTEMI)","guideline_source":"Antman EM et al. The TIMI risk score for UA/NSTEMI. JAMA 2000; calculator_helper"},{"engine_number":123,"instrument":"GRACE Risk Score (ACS, simplified deterministic)","guideline_source":"Fox KAA et al. BMJ 2006 (GRACE); calculator_helper"},{"engine_number":124,"instrument":"HEART Score (chest pain / ACS risk)","guideline_source":"Six AJ et al. Neth Heart J 2008; Backus BE et al. 2010 (HEART score)"},{"engine_number":125,"instrument":"NIHSS (NIH Stroke Scale)","guideline_source":"Brott T et al. Stroke 1989; NINDS NIHSS"},{"engine_number":126,"instrument":"ICH Score (Hemphill 2001)","guideline_source":"Hemphill JC et al. Stroke 2001 (ICH score); calculator_helper"},{"engine_number":127,"instrument":"Hunt-Hess SAH grading (Hunt & Hess 1968)","guideline_source":"Hunt WE, Hess RM. J Neurosurg 1968 (Hunt-Hess); calculator_helper"},{"engine_number":128,"instrument":"Fisher SAH grading (Fisher 1980)","guideline_source":"Fisher CM et al. Neurosurgery 1980 (Fisher scale); calculator_helper"},{"engine_number":129,"instrument":"Coma assessment: GCS + FOUR score","guideline_source":"Teasdale & Jennett, Lancet 1974 (GCS); Wijdicks et al. Ann Neurol 2005 (FOUR)"},{"engine_number":130,"instrument":"Glasgow-Blatchford Bleeding Score (Blatchford 2000)","guideline_source":"Blatchford O et al. Lancet 2000 (GBS); calculator_helper"},{"engine_number":131,"instrument":"Rockall Score (GI bleed, pre-endoscopy)","guideline_source":"Rockall TA et al. Gut 1996 (Rockall score); calculator_helper"},{"engine_number":132,"instrument":"Ranson Criteria (acute pancreatitis, non-gallstone)","guideline_source":"Ranson JH et al. Surg Gynecol Obstet 1974 (Ranson criteria); calculator_helper"},{"engine_number":133,"instrument":"BISAP Score (acute pancreatitis mortality)","guideline_source":"Wu BU et al. Gut 2008 (BISAP); calculator_helper"},{"engine_number":134,"instrument":"MELD / MELD-Na (Kamath 2001; Kim 2008)","guideline_source":"Kamath PS et al. Hepatology 2001 (MELD); Kim WR et al. NEJM 2008 (MELD-Na)"},{"engine_number":135,"instrument":"FIB-4 Index (liver fibrosis, non-invasive)","guideline_source":"Sterling RK et al. Hepatology 2006 (FIB-4); calculator_helper"},{"engine_number":136,"instrument":"Burch-Wartofsky Point Scale (thyroid storm)","guideline_source":"Burch HB, Wartofsky L. Endocrinol Metab Clin 1993 (BWPS); calculator_helper"},{"engine_number":137,"instrument":"Acetaminophen (APAP) Rumack-Matthew nomogram","guideline_source":"Rumack BH, Matthew H. Pediatrics 1975 (Rumack-Matthew nomogram); calculator_helper"},{"engine_number":138,"instrument":"Toxic-alcohol & salicylate severity (AAPCC framing)","guideline_source":"AACT/AAPCC toxicology practice guidance; Done AK salicylate framing"},{"engine_number":139,"instrument":"DAS28 (RA disease activity, EULAR)","guideline_source":"van der Heijde DM et al.; EULAR DAS28 response criteria"},{"engine_number":140,"instrument":"SCORTEN (SJS/TEN severity-of-illness)","guideline_source":"Bastuji-Garin S et al. J Invest Dermatol 2000 (SCORTEN); calculator_helper"},{"engine_number":141,"instrument":"ADD-RS (Aortic Dissection Detection Risk Score)","guideline_source":"Rogers AM et al. Circulation 2011; 2010 ACCF/AHA thoracic aortic guideline"},{"engine_number":142,"instrument":"TWIST (Testicular Workup for Ischemia and Suspected Torsion)","guideline_source":"Barbosa JA et al. J Urol 2013 (TWIST score); calculator_helper"},{"engine_number":143,"instrument":"DIC ISTH overt score (Taylor 2001)","guideline_source":"Taylor FB et al. (ISTH SSC) Thromb Haemost 2001 (overt-DIC score); calculator_helper"},{"engine_number":144,"instrument":"ITP platelet-threshold tiers (ASH 2019)","guideline_source":"Neunert C et al. ASH 2019 ITP guidelines; calculator_helper"},{"engine_number":145,"instrument":"Pressure Injury Risk (Braden / Norton)","guideline_source":"Bergstrom N et al. (Braden Scale); NPIAP 2019 pressure injury prevention"},{"engine_number":146,"instrument":"Rapid Response / MET activation criteria (MERIT)","guideline_source":"MERIT Study (Lancet 2005); standard RRT/MET activation criteria"},{"engine_number":147,"instrument":"Pain assessment tools (PAINAD / NRS / FACES)","guideline_source":"Warden V et al. (PAINAD 2003); Wong-Baker FACES"},{"engine_number":148,"instrument":"Goals of care / POLST / MOLST prompts","guideline_source":"National POLST; serious-illness conversation guides"},{"engine_number":149,"instrument":"Readmission risk (LACE / HOSPITAL)","guideline_source":"van Walraven C et al. CMAJ 2010 (LACE); Donzé J et al. JAMA IM 2013 (HOSPITAL)"},{"engine_number":150,"instrument":"Pneumonia classification (CAP / HAP / VAP)","guideline_source":"Kalil AC et al. ATS/IDSA 2016 (HAP/VAP); Metlay JP et al. ATS/IDSA 2019 (CAP)"},{"engine_number":151,"instrument":"Inpatient hyperglycemia management (ADA inpatient)","guideline_source":"ADA Standards of Care — Diabetes Care in the Hospital (2023); calculator_helper"},{"engine_number":152,"instrument":"Heart failure staging (NYHA + MAGGIC/KCCQ framing)","guideline_source":"NYHA functional classification; Pocock SJ et al. (MAGGIC)"},{"engine_number":153,"instrument":"COPD GOLD staging + asthma control (ACT/ACQ)","guideline_source":"GOLD 2024 (COPD); GINA 2024 + ACT/ACQ (asthma)"},{"engine_number":154,"instrument":"Cognitive screening (MoCA / Mini-Cog / AD8)","guideline_source":"Nasreddine ZS et al. 2005 (MoCA); Mini-Cog"},{"engine_number":155,"instrument":"Frailty (Clinical Frailty Scale + FRAIL index)","guideline_source":"Rockwood K et al. CMAJ 2005 (CFS); Morley JE et al. (FRAIL)"},{"engine_number":156,"instrument":"Hereditary cancer risk (BRCA / Lynch / Li-Fraumeni, NCCN)","guideline_source":"NCCN Genetic/Familial High-Risk Assessment guidelines; calculator_helper"},{"engine_number":157,"instrument":"Immunization gap detector (CDC ACIP)","guideline_source":"CDC ACIP adult immunization schedule; calculator_helper"},{"engine_number":158,"instrument":"Substance-use screening (AUDIT-C / CAGE / NIDA-ASSIST)","guideline_source":"AUDIT-C (Bush 1998); CAGE"},{"engine_number":159,"instrument":"Diabetes complication-screening tracker (ADA 2024)","guideline_source":"ADA Standards of Care 2024 (microvascular complications); calculator_helper"},{"engine_number":160,"instrument":"Hypertension staging (ACC/AHA 2017)","guideline_source":"Whelton PK et al. ACC/AHA 2017 hypertension guideline; calculator_helper"},{"engine_number":161,"instrument":"Wells DVT pre-test probability (Wells 2003)","guideline_source":"Wells PS et al. NEJM 2003 (DVT Wells); calculator_helper"},{"engine_number":162,"instrument":"CURB-65 community-acquired pneumonia severity (Lim 2003)","guideline_source":"Lim WS et al. Thorax 2003 (CURB-65); calculator_helper"},{"engine_number":163,"instrument":"Child-Pugh cirrhosis severity class (Pugh 1973)","guideline_source":"Pugh RNH et al. Br J Surg 1973 (Child-Pugh); calculator_helper"},{"engine_number":164,"instrument":"Centor / McIsaac score for streptococcal pharyngitis","guideline_source":"Centor RM et al. Med Decis Making 1981; McIsaac WJ et al. CMAJ 1998"},{"engine_number":165,"instrument":"COWS opioid-withdrawal severity (Wesson & Ling 2003)","guideline_source":"Wesson DR, Ling W. J Psychoactive Drugs 2003 (COWS); calculator_helper"},{"engine_number":166,"instrument":"PEN-FAST penicillin-allergy delabeling risk (Trubiano 2020)","guideline_source":"Trubiano JA et al. JAMA Intern Med 2020 (PEN-FAST); calculator_helper"},{"engine_number":167,"instrument":"Charlson Comorbidity Index (Charlson 1987)","guideline_source":"Charlson ME et al. J Chronic Dis 1987 (CCI); calculator_helper"},{"engine_number":168,"instrument":"Maddrey Discriminant Function (alcoholic hepatitis)","guideline_source":"Maddrey WC et al. Gastroenterology 1978 (DF); calculator_helper"},{"engine_number":169,"instrument":"Psoriasis / atopic-dermatitis severity (BSA → PASI / SCORAD)","guideline_source":"AAD/NPF psoriasis guidelines; AAD atopic dermatitis guidelines (PASI/EASI/SCORAD)"},{"engine_number":170,"instrument":"Westley croup severity score","guideline_source":"Westley CR et al. Am J Dis Child 1978 (Westley croup score); calculator_helper"},{"engine_number":171,"instrument":"sPESI (simplified Pulmonary Embolism Severity Index)","guideline_source":"Jiménez D et al. Arch Intern Med 2010 (sPESI)"},{"engine_number":172,"instrument":"Revised Geneva score (pulmonary embolism clinical probability)","guideline_source":"Le Gal G et al. Ann Intern Med 2006 (revised Geneva)"},{"engine_number":173,"instrument":"Padua Prediction Score (medical-inpatient VTE risk)","guideline_source":"Barbar S et al. J Thromb Haemost 2010 (Padua)"},{"engine_number":174,"instrument":"Sgarbossa criteria (acute MI in LBBB / ventricular-paced rhythm)","guideline_source":"Sgarbossa EB et al. NEJM 1996; Smith SW et al. Ann Emerg Med 2012 (modified)"},{"engine_number":175,"instrument":"San Francisco Syncope Rule (CHESS)","guideline_source":"Quinn JV et al. Ann Emerg Med 2004 (San Francisco Syncope Rule)"},{"engine_number":176,"instrument":"NEXUS low-risk criteria (cervical-spine imaging clearance)","guideline_source":"Hoffman JR et al. NEJM 2000 (NEXUS)"},{"engine_number":177,"instrument":"ABCD2 score (early stroke risk after TIA)","guideline_source":"Johnston SC et al. Lancet 2007 (ABCD2)"},{"engine_number":178,"instrument":"Canadian CT Head Rule (minor head injury)","guideline_source":"Stiell IG et al. Lancet 2001 (Canadian CT Head Rule)"},{"engine_number":179,"instrument":"SIRS criteria (Systemic Inflammatory Response Syndrome)","guideline_source":"Bone RC et al. Chest 1992 (ACCP/SCCM SIRS consensus); Levy MM et al. Crit Care Med 2003"},{"engine_number":180,"instrument":"SOFA score (Sequential Organ Failure Assessment, full)","guideline_source":"Vincent JL et al. Intensive Care Med 1996 (SOFA); Singer M et al. JAMA 2016 (Sepsis-3)"},{"engine_number":181,"instrument":"RCRI (Revised Cardiac Risk Index, Lee 1999)","guideline_source":"Lee TH et al. Circulation 1999 (RCRI); 2024 ACC/AHA perioperative guideline"},{"engine_number":182,"instrument":"PSI / PORT (Pneumonia Severity Index, Fine 1997)","guideline_source":"Fine MJ et al. NEJM 1997 (PSI/PORT); Metlay JP et al. ATS/IDSA 2019 CAP guideline"},{"engine_number":183,"instrument":"EDACS (Emergency Department Assessment of Chest pain Score)","guideline_source":"Than M et al. Emerg Med Australas 2014 (EDACS); Flaws D et al. 2016 (EDACS-ADP)"},{"engine_number":184,"instrument":"AIMS65 (upper-GI-bleed in-hospital mortality)","guideline_source":"Saltzman JR et al. Gastrointest Endosc 2011 (AIMS65)"},{"engine_number":185,"instrument":"Glasgow-Imrie criteria (acute pancreatitis severity)","guideline_source":"Blamey SL et al. Gut 1984 (Glasgow/Imrie); Mounzer R et al. Gastroenterology 2012 (comparison)"},{"engine_number":186,"instrument":"Ottawa SAH Rule (subarachnoid haemorrhage in acute headache)","guideline_source":"Perry JJ et al. JAMA 2013 (Ottawa SAH Rule); BMJ 2020 validation"},{"engine_number":187,"instrument":"West Haven criteria (hepatic encephalopathy grading)","guideline_source":"Vilstrup H et al. Hepatology 2014 (AASLD/EASL HE guideline, West Haven)"},{"engine_number":188,"instrument":"APRI (AST-to-Platelet Ratio Index)","guideline_source":"Wai CT et al. Hepatology 2003 (APRI); WHO Hepatitis C guidelines 2018"},{"engine_number":189,"instrument":"NAFLD Fibrosis Score (NFS)","guideline_source":"Angulo P et al. Hepatology 2007 (NAFLD Fibrosis Score); AASLD 2023 NAFLD guidance"},{"engine_number":190,"instrument":"Forrest classification (peptic-ulcer bleeding stigmata)","guideline_source":"Forrest JA et al. Lancet 1974; Laine L, Jensen DM. ACG 2012 (UGIB management)"},{"engine_number":191,"instrument":"Alvarado score (acute appendicitis probability)","guideline_source":"Alvarado A. Ann Emerg Med 1986 (Alvarado score)"},{"engine_number":192,"instrument":"LRINEC score (necrotizing soft-tissue infection risk)","guideline_source":"Wong CH et al. Crit Care Med 2004 (LRINEC)"},{"engine_number":193,"instrument":"Modified Duke criteria (infective endocarditis)","guideline_source":"Li JS et al. Clin Infect Dis 2000 (modified Duke); AHA IE Scientific Statement 2015"},{"engine_number":194,"instrument":"Light's criteria (pleural effusion: exudate vs transudate)","guideline_source":"Light RW et al. Ann Intern Med 1972 (Light's criteria)"},{"engine_number":195,"instrument":"STOP-BANG (obstructive sleep apnea risk, computed 8-point)","guideline_source":"Chung F et al. Anesthesiology 2008 (STOP-BANG); Nagappa M et al. PLoS One 2015"},{"engine_number":196,"instrument":"PECARN pediatric head-injury rule (ciTBI risk)","guideline_source":"Kuppermann N et al. Lancet 2009 (PECARN head-injury rules)"},{"engine_number":197,"instrument":"PEWS (Pediatric Early Warning Score, escalation screen)","guideline_source":"Monaghan A. Paediatr Nurs 2005 (Brighton PEWS); RCPCH PEWS national framework 2023"},{"engine_number":198,"instrument":"Bishop score (cervical favorability for labor induction)","guideline_source":"Bishop EH. Obstet Gynecol 1964 (Bishop score); ACOG induction-of-labor guidance"},{"engine_number":199,"instrument":"Apgar score (newborn condition at 1 and 5 minutes)","guideline_source":"Apgar V. Curr Res Anesth Analg 1953; AAP/AHA NRP 8th ed. 2021"},{"engine_number":200,"instrument":"Kocher criteria (paediatric septic arthritis of the hip)","guideline_source":"Kocher MS et al. J Bone Joint Surg Am 1999; Caird MS et al. 2006 (validation + CRP)"},{"engine_number":201,"instrument":"STONE score (predicting uncomplicated ureteral stone)","guideline_source":"Moore CL et al. BMJ 2014 (STONE score)"},{"engine_number":202,"instrument":"Parkland formula + Rule of Nines (burn fluid resuscitation)","guideline_source":"Baxter CR, Shires GT. Ann N Y Acad Sci 1968 (Parkland); ABA Advanced Burn Life Support"},{"engine_number":203,"instrument":"FeNa (Fractional Excretion of Sodium)","guideline_source":"Espinel CH. JAMA 1976 (FeNa); KDIGO 2012 AKI guideline (work-up)"},{"engine_number":204,"instrument":"Neuroleptic Malignant Syndrome (NMS)","guideline_source":"Levenson JL. Am J Psychiatry 1985 (NMS criteria); DSM-5-TR NMS"},{"engine_number":205,"instrument":"Serotonin Syndrome (Hunter Criteria)","guideline_source":"Dunkley EJC et al. QJM 2003 (Hunter criteria); Boyer EW, Shannon M."},{"engine_number":206,"instrument":"Spinal Epidural Abscess (MRI-now decision)","guideline_source":"Reihsaus E et al. Neurosurg Rev 2000; Davis DP et al. J Emerg Med 2004"},{"engine_number":207,"instrument":"Acute Mesenteric Ischemia","guideline_source":"Bala M et al. WSES guidelines 2017 (acute mesenteric ischemia)"},{"engine_number":208,"instrument":"Hypertensive Emergency vs Urgency","guideline_source":"Whelton PK et al. ACC/AHA 2017 hypertension guideline; van den Born"},{"engine_number":210,"instrument":"Therapeutic Drug Monitoring (TDM)","guideline_source":"ISMP High-Alert Medications 2024; drug prescribing information / TDM"},{"engine_number":211,"instrument":"Anticoagulation Monitoring + Transition Safety","guideline_source":"Institute for Safe Medication Practices (ISMP) High-Alert Medications"},{"engine_number":null,"instrument":"Adrenal (Addisonian) Crisis — Recognition + Immediate Steroid","guideline_source":"Endocrine Society Clinical Practice Guideline 2016 (Diagnosis and"},{"engine_number":null,"instrument":"Antimicrobial Stewardship — Duration + IV-to-PO Switch + Stop Date","guideline_source":"IDSA/SHEA Implementing an Antibiotic Stewardship Program (2016); CDC"},{"engine_number":null,"instrument":"ARDS (Berlin) Recognition + Hypoxemic-Failure Escalation","guideline_source":"ARDS Definition Task Force (Berlin Definition), JAMA 2012"},{"engine_number":null,"instrument":"Behavioral Health Engine (Expansion)","guideline_source":"DSM-5-TR; USPSTF depression/anxiety screening (PHQ-9, GAD-7), Columbia C-SSRS"},{"engine_number":null,"instrument":"Suspected-Cancer Referral (NICE NG12 Two-Week-Wait Pattern)","guideline_source":"NICE NG12 Suspected cancer: recognition and referral (2015, updated"},{"engine_number":null,"instrument":"Clostridioides difficile — Severity & Management","guideline_source":"IDSA/SHEA 2021 focused update on C. difficile; ACG 2021 CDI guideline."},{"engine_number":null,"instrument":"Chronic Disease Completion Engine","guideline_source":"KDIGO CKD; ACR gout/arthritis, NCEP ATP III metabolic syndrome, ATA thyroid"},{"engine_number":null,"instrument":"Engine — CKD / Dialysis Anemia Management (KDIGO)","guideline_source":"KDIGO 2012 Clinical Practice Guideline for Anemia in CKD; KDIGO 2024/25"},{"engine_number":null,"instrument":"Diabetic Foot Infection — IDSA/IWGDF Severity + Osteomyelitis","guideline_source":"IWGDF/IDSA 2023 Guideline on diagnosis and treatment of foot infection"},{"engine_number":null,"instrument":"Drug Interaction Engine — High-Yield Pairs","guideline_source":"FDA"},{"engine_number":null,"instrument":"Ectopic Pregnancy — Risk Recognition + hCG Discriminatory Zone","guideline_source":"ACOG Practice Bulletin 193 (Tubal Ectopic Pregnancy); NICE NG126"},{"engine_number":null,"instrument":"Emergency Medicine Engine","guideline_source":"ATLS"},{"engine_number":null,"instrument":"Evidence Integrity Engine — Truth-Guard Layer","guideline_source":"FDA"},{"engine_number":null,"instrument":"Facial Weakness — Bell's Palsy vs Central (Stroke) Discriminator","guideline_source":"AAN/AAO-HNS Bell's Palsy Guideline (Baugh 2013); stroke recognition"},{"engine_number":null,"instrument":"Geriatric Engine — Age >= 65","guideline_source":"CDC STEADI falls prevention; AGS Beers Criteria (polypharmacy), CAM delirium"},{"engine_number":null,"instrument":"Giant Cell (Temporal) Arteritis — Vision-Threat Recognition","guideline_source":"ACR/Vasculitis Foundation 2021 Guideline for the Management of Giant"},{"engine_number":null,"instrument":"Global Outpatient / Public Health Completion Engine","guideline_source":"WHO IMCI; WHO community & public-health outpatient guidance (anemia, ORS, infestation)"},{"engine_number":null,"instrument":"HIV / STI / Communicable Disease Engine","guideline_source":"CDC STI Treatment Guidelines; WHO consolidated HIV guidelines"},{"engine_number":null,"instrument":"Hyperkalemia — Treatment Ladder + ECG-Severity Link","guideline_source":"UK Renal Association / KDIGO hyperkalemia management; AHA ACLS"},{"engine_number":null,"instrument":"Severe Hyponatremia — Correction-Rate Safety (Osmotic Demyelination Guard)","guideline_source":"Spasovski G et al. European Clinical Practice Guideline on the"},{"engine_number":null,"instrument":"Infectious Disease Expansion Engine","guideline_source":"Surviving Sepsis Campaign (Sepsis-3); IDSA guidelines (meningitis, pneumonia, UTI)"},{"engine_number":null,"instrument":"Kawasaki Disease — Prolonged Pediatric Fever + Principal Criteria","guideline_source":"AHA 2017 Scientific Statement — Diagnosis, Treatment, and Long-Term"},{"engine_number":null,"instrument":"Lab Interpretation Engine — Full Pathology Coverage","guideline_source":"Standard clinical laboratory reference ranges (CLSI); age/sex-adjusted critical-value thresholds"},{"engine_number":null,"instrument":"Magnesium Sulfate Toxicity Monitoring (Pre-eclampsia / Eclampsia)","guideline_source":"ACOG (Gestational Hypertension and Preeclampsia); WHO recommendations"},{"engine_number":null,"instrument":"Male Health Engine","guideline_source":"AUA guidelines (BPH/LUTS, ED, prostate cancer); EAU urology, AUA acute scrotum"},{"engine_number":null,"instrument":"Massive / Submassive Pulmonary Embolism — Risk-Stratified Pathway","guideline_source":"Konstantinides SV et al. ESC 2019 Guidelines on Acute Pulmonary"},{"engine_number":null,"instrument":"Bacterial Meningitis — Empiric Antibiotic Clock","guideline_source":"IDSA Practice Guidelines for Bacterial Meningitis (Tunkel 2004)"},{"engine_number":null,"instrument":"Acute Myocarditis","guideline_source":"ESC 2013 position statement on myocarditis; AHA Scientific Statement"},{"engine_number":null,"instrument":"Neuro Expansion Engine","guideline_source":"AHA; NIHSS"},{"engine_number":null,"instrument":"Maternal / Obstetric Sepsis — Modified Obstetric Early-Warning","guideline_source":"RCOG Green-top Guideline 64 (Sepsis in/following Pregnancy)"},{"engine_number":null,"instrument":"Ophthalmology Engine","guideline_source":"AAO Preferred Practice Patterns; Wills Eye Manual (ocular emergencies)"},{"engine_number":null,"instrument":"Pediatric Sepsis / Septic Shock — Weight-Based Escalation","guideline_source":"Surviving Sepsis Campaign International Guidelines for Children 2020"},{"engine_number":null,"instrument":"Pheochromocytoma — Paroxysmal Catecholamine-Excess Pattern","guideline_source":"Lenders JWM et al. Endocrine Society Clinical Practice Guideline 2014"},{"engine_number":null,"instrument":"Post-Op / Nursing / PT Care Engine","guideline_source":"ERAS Society perioperative care; AORN perioperative & Indian Nursing Council standards"},{"engine_number":null,"instrument":"Preoperative / Anesthesia Risk Engine","guideline_source":"ACC/AHA; AHA"},{"engine_number":null,"instrument":"Preventive Health / IPV Engine","guideline_source":"USPSTF IPV screening (HITS/HARK); CDC IPV prevention, USPSTF behavioral counseling"},{"engine_number":null,"instrument":"Radiology Findings Engine — Comprehensive Imaging Interpretation","guideline_source":"ACR"},{"engine_number":null,"instrument":"SOVEREIGN CLINICAL STANDARD ENGINE","guideline_source":"P.AI Global Health Medical Symptoms Database (347 diseases)"},{"engine_number":null,"instrument":"Sports Medicine / Injury Engine","guideline_source":"Concussion in Sport Group consensus (SCAT); Ottawa Ankle/Knee Rules, ACSM return-to-play"},{"engine_number":null,"instrument":"Status Epilepticus — Time-Based Treatment Ladder","guideline_source":"Neurocritical Care Society Guideline (Brophy 2012); AES 2016 guideline"},{"engine_number":null,"instrument":"Substance Use + PTSD Engine","guideline_source":"DSM-5-TR (SUD, PTSD); AUDIT-C/CAGE alcohol screening, PCL-5 PTSD checklist"},{"engine_number":null,"instrument":"Complementary Medicine / Supplement Safety Engine","guideline_source":"FDA"},{"engine_number":null,"instrument":"Tuberculosis — Active vs Latent + Airborne Isolation & Notification","guideline_source":"WHO Consolidated TB Guidelines 2022; CDC/ATS/IDSA TB diagnosis &"},{"engine_number":null,"instrument":"Toxic Shock Syndrome (TSS)","guideline_source":"CDC TSS case definition; Lappin & Ferguson Lancet Infect Dis 2009"},{"engine_number":null,"instrument":"Acute Toxidrome — Sympathomimetic & Anticholinergic","guideline_source":"Goldfrank's Toxicologic Emergencies; ACMT toxidrome recognition."},{"engine_number":null,"instrument":"Tropical + Global Infectious Disease Engine","guideline_source":"WHO guidelines (malaria, dengue, TB); ICMR India infectious-disease protocols"},{"engine_number":null,"instrument":"USPSTF Preventive Recommendations Engine — Feb 2026 build (Resource 5).","guideline_source":"https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics"},{"engine_number":null,"instrument":"Women's Health Engine","guideline_source":"ACOG"}],"regression_pass":2106,"regression_total":2110,"synthetic_critical":"52/52","synthetic_negation":"15/15","synthetic_cross_engine":"6/6","synthetic_priority_filter":"3/3","safety_stack_layers":8,"patent_claims":54,"languages":25,"channels":["web","voice","telegram","whatsapp","ambient_scribe"],"moats":["Moat 1 — Per-flag source decorator (FDA §3060 CDS carve-out)","Moat 2 — Physician attestation hash chain (HIPAA §164.312(c)(2))","Engine 68 — Off-label malpractice shield (Wyeth v. Levine + Buckman)","30 patent claims pending (18 original + 12 extended)","LLM-boundary architectural attestation per flag (llm_in_decision:false)"],"users":1,"founder_team_self_test_encounters":109,"yc_demo_encounters":4,"ambient_scribe_encounters":0,"system_test_encounters":132,"encounters":251,"registrations":56,"counter":109,"last_updated":"2026-07-15","deterministic":true,"llm_in_clinical_decision_loop":false}